Serving leading biopharmaceutical companies globally:

Last Updated: October 14, 2019

DrugPatentWatch Database Preview

Drug Sales Trends for OMEPRAZOLE

See Plans and Pricing

« Back to Dashboard

Payment Methods and Pharmacy Types for OMEPRAZOLE (2017)

Revenues by Pharmacy Type

Chart
Table

Pharmacy Type	Revenues
MAIL-ORDER	$288,593,919
INSIDE ANOTHER STORE	$755,312,371
[disabled in preview]	$2,229,604,569
This preview shows a limited data set Subscribe for full access, or try a Trial

Units Sold by Pharmacy Type

Chart
Table

Pharmacy Type	Units
MAIL-ORDER	5,688,387
INSIDE ANOTHER STORE	13,950,237
[disabled in preview]	35,792,208
This preview shows a limited data set Subscribe for full access, or try a Trial

Revenues by Payment Method

Chart
Table

Payment Method	Revenues
MEDICAID	$302,431,217
MEDICARE	$890,943,074
[disabled in preview]	$2,083,692,562
This preview shows a limited data set Subscribe for full access, or try a Trial

Drug Sales Revenue Trends for OMEPRAZOLE

Drug Units Sold Trends for OMEPRAZOLE

Annual Sales Revenues and Units Sold for OMEPRAZOLE

These sales figures are drawn from a US national survey of drug expenditures

Subscribe to access the full database, or request a copy of the full page.
Drug Name	Revenues (USD)	Units	Year
OMEPRAZOLE	See Pricing	See Pricing	2017
OMEPRAZOLE	See Pricing	See Pricing	2016
OMEPRAZOLE	See Pricing	See Pricing	2015
OMEPRAZOLE	See Pricing	See Pricing	2014
OMEPRAZOLE	See Pricing	See Pricing	2013
OMEPRAZOLE	See Pricing	See Pricing	2012
OMEPRAZOLE	See Pricing	See Pricing	2011
>Drug Name	>Revenues (USD)	>Units	>Year

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School

Merck

Moodys

Boehringer Ingelheim

Johnson and Johnson

Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

By using our website you are consenting to our use of cookies in accordance with our privacy policy.